tumour pathology week 6 Flashcards
what is aetiology
what causes disease
what is pathogenesis
how a disease develops and progresses
what is neoplasia
the uncontrolled, abnormal growth of cells or tissues in body
what is classification of tumours based on
- tissue of origin
- benign vs. malignant
nomenclature of epithelial tumours
glandular benign: adenoma malignant: adenocarcoma squamous benign: squamous papilloma malignant: squamous carcinoma
nomenclature of connective tissue tumours
bone benign = osteoma malignant = osteosarcoma fat benign = lipoma malignant - liposarcoma fibrous tissue benign = fibroma malignant = fibrosarcoma
nomenclature of tumours of blood cells
white blood cells
malignant = leukaemia
- no known benign tumours of WBC
- no known tumours of red blood cells
nomenclature of tumours of lymphoid tissue
malignant = lymphoma
- no known benign tumours of lymphoid tissue
nomenclature of tumours of melanocytes
benign = naevus malignant = melanoma
nomenclature of neural tissue
central nervous system = astrocytoma
peripheral nervous system = shwannoma
nomenclature of germ cells tumours
- germ cells (testes/ovaries)
- teratomas
- tumour can be composed of various tissue because they are stem cells
- ovarian teratomas usually benign
- testicular teratomas usually malignant
what are some features of benign tumours
- non-invasive growth pattern
- usually encapsulated
- no evidence of invasion
- no metastases
- cells similar to normal
- ‘well differentiated’
- function similar to normal tissue
- rarely cause death
what are some features of malignant tumours
- invasive growth pattern
- no capsule or capsule breached by tumour cells
- cells abnormal
- ‘poorly differentiated’
- loss of normal function
- often evidence of spread of cancer
- frequently cause death
what are some properties of cancer cells
- loss of tumour suppressor genes (BRCA1, Rb)
- gain of function of oncogenes (B-raf, cyclin D1)
- altered cellular function
- abnormal morphology
- cells capable of independent growth
what happens to cellular function in cancer
- loss of cell to cell adhesion
- altered cell to cell matrix adhesion
- production of tumour related proteins
what are tumour biomarkers
- any properties of cancer cells that can be exploited clinically
- Onco-foetal proteins (present in foetus, switched off post natal, switched on again in tumours), oncogenes, growth factors and receptors, immune checkpoint inhibitors
what are some examples of clinically useful predictive biomarkers
Kras = colorectal cancer Braf = melanoma EGFR = lung cancer PD-L1 = lung cancer Her2 = breast cancer, gastric cancer
what is morphology of cancer
- histology of cancer
- cellular and nuclear pleomorphism
- mitoses present and often abnormal
what is tumour growth a balance of
- cell growth and cell death
- angiogenesis and apoptosis
what is tumour angiogenesis
- new blood vessel formation by tumours
- required to sustain tumour growth
- provides route for release of tumour cells into circulation
- more blood vessels in a tumour = poorer prognosis
what is apoptosis
- mechanism of programmed single cell death
- active cell process
- regulates tumour growth
- involved in response to chemo and radio therapy
how does metastasis begin
- increased matrix degradation by proteolytic enzymes
- altered cell-to-cell and cell-to-matrix adhesion
what are the modes of spread of cancer
- local spread (spread into adjacent structures, invasion)
- lymphatic spread
- blood spread
- trans-coelomic spread (through body cavities)(lung, stomach, colon and ovary cancers)(e.g. pleural or peritoneal cavities)